SymKardia, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-28.
SymKardia, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 28, 2026. The filing reports $4M sold. Its industry group is Other Health Care. It names Anthony Caparso (Executive Officer, Director), Bruce KenKnight (Executive Officer), Steven Girouard (Executive Officer) (SEC Form D, October 28, 2026).
Selling to SymKardia, Inc.? See who runs it and how to reach them, plus this week's 44 other newly funded companies.
Is this your company?
Sell to companies like SymKardia, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns SymKardia, Inc.
Free to see. No signup.
More on the people and the money behind SymKardia, Inc., from the filings we hold.
Other Health Care raises by companies based in Ohio, filed within 90 days of this one, largest first.
Get an email when SymKardia, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when SymKardia, Inc. raises, hires or launches. No email unless you switch it on.
Watch SymKardia, Inc. →Get the full cited report on SymKardia, Inc.
What the filing shows about SymKardia, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on SymKardia, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives SymKardia, Inc.'s address as 159 Crocker Park Boulevard, Suite 400, Westlake, OH 44145.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for SymKardia, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
SymKardia, Inc. is a registered filer with the SEC (CIK 2141283) and has filed since 2026-06-18. 2 filings are on record, the latest on 2026-10-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
SymKardia, Inc.'s Form D of 2026-10-28 names Anthony Caparso, Bruce KenKnight, Steven Girouard and 8 more as its officers, directors or promoters.
Its new offerings report $4.50M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 871 filings in Other Health Care, totalled by week. The dot is this raise, $4M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Anthony Caparso is named as Executive Officer and Director on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
Bruce KenKnight is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
Steven Girouard is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
Jonathan Piccini is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
Imad Libbus is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
Dwight Skinner is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
Robert Picarel is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
Arun Sridhar is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
Claudio Rumazza is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
Alain Garcinuno Collet is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
James Blouzard is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 28 October 2026, one of 11 people that filing names.
11 people named on the filing — 6 holding an executive role and 5 as directors only.
Named as of the 2026-10-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about SymKardia, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on SymKardia, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SymKardia, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SymKardia, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind SymKardia, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for SymKardia, Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-10-26 · Health care raises, week of 2026-10-26
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/symkardia-inc-form-d-000002